Project Details
| Status | Active |
|---|---|
| Effective start/end date | 19/05/23 → 18/05/28 |
Funding
- Boehringer Ingelheim GmbH: £2,999,645.78
NASH Disease Translational Accelerator (Prospective Study 2)
- Henderson, Neil (Principal Investigator)
| Status | Active |
|---|---|
| Effective start/end date | 19/05/23 → 18/05/28 |